株探米国株
英語
エドガーで原本を確認する
6-K 1 ea0264884-6k_sapiens.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

 

For the month of November 2025

 

Commission File Number 000-20181

 

SAPIENS INTERNATIONAL CORPORATION N.V.

(Translation of registrant’s name into English)

 

Azrieli Center

26 Harokmim St.

Holon, 5885800 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒         Form 40-F ☐

 

 

 

 


 

CONTENTS

 

Exhibits

 

The following exhibit is furnished as part of this Form 6-K:

 

Exhibit     Description
99.1   Press release

 

1


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SAPIENS INTERNATIONAL CORPORATION N.V.
   
Date: November 13, 2025 By: /s/ Roni Giladi
    Name:  Roni Giladi
    Title: Chief Financial Officer

 

2

 

EX-99.1 2 ea026488401ex99-1_sapiens.htm PRESS RELEASE

Exhibit 99.1

 

 

Sapiens Reports Third Quarter 2025 Financial Results

 

Rochelle Park, NJ, November 13, 2025 – Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2025.

 

Summary Results for Third Quarter 2025 (USD in millions, except per share data)

 

    GAAP           Non-GAAP        
    Q3 2025     Q3 2024     % Change     Q3 2025     Q3 2024     % Change  
Revenue   $ 152.3     $ 137.0       11.2 %   $ 152.3     $ 137.0       11.2 %
Gross Profit   $ 67.3     $ 60.3       11.6 %   $ 70.7     $ 62.8       12.5 %
Gross Margin     44.2 %     44.0 %      20 bps       46.4 %     45.8 %     60 bps  
Operating Income   $ 17.8     $ 21.7       -18.3 %   $ 25.5     $ 25.1       1.5 %
Operating Margin     11.7 %     15.9 %      -420 bps       16.7 %     18.3 %     -160 bps  
Net Income (*)   $ 14.3     $ 18.3       -22.0 %   $ 20.5     $ 21.1       -2.7 %
Diluted EPS   $ 0.25     $ 0.33       -24.2 %   $ 0.36     $ 0.37       -2.7 %

 

(*) Attributable to Sapiens’ shareholders

 

Roni Al-Dor, President and CEO of Sapiens, stated, “In the third quarter of 2025, we continued to execute on our strategic priorities, securing new deals and strengthening customer relationships globally. Revenue increased by 11.2% year-over-year, reaching $152 million for the quarter. All our top geographic markets grew in the quarter, led by double digit expansion in North America and Rest of the World, reflecting broad-based demand and the successful execution of our strategic initiatives. Our annualized recurring revenue (ARR) totaled $220 million, reflecting a 26.7% year-over-year increase, of which 17.5% is organic and 9.2% contributed from the recent acquisitions. Sapiens’s non-GAAP operating profit totaled $25 million in the quarter, reflecting a 16.7% operating margin.

 

Our insurance platform empowers insurers to accelerate digital transformation, achieve sustainable growth, and operational efficiency, fueled by the continued adoption of AI-driven innovation. We remain committed to advancing our platform, accelerating cloud adoption, and expanding our global footprint, all of which will serve as catalysts for continued success. Our continued success in both new customer acquisition and account expansion across North America and EMEA underscores the strategic value of our platform for insurers accelerating digital transformation.”

 

Following Sapiens’ announcement on August 12, 2025, that the company has entered into a definitive agreement to be acquired by Advent, a leading global private equity investor, for $43.50 per common share in cash, valuing Sapiens at approximately $2.5 billion, Sapiens will forgo a Q3 2025 Earnings Call.

 

1


 

Non-GAAP Financial Measures

 

This press release contains the following non-GAAP financial measures: non-GAAP revenue, ARR, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens’ financial condition and results of operations. The Company’s management uses these non-GAAP measures to compare the Company’s performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company’s board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company’s financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

 

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments.

 

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

 

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company’s business.

 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

 

The Company defines Annual Recurring Revenue (“ARR”) as the annualized value of our revenue from customer subscriptions, term licenses, maintenance, application maintenance, and cloud solutions, which may not be the same as the timing and amount of revenue recognized. The ARR run rate is equal to the product of (i) the sum of these revenues in our most recently completed fiscal quarter, multiplied by (ii) four.

 

2


 

The Company defines Adjusted EBITDA as net profit, adjusted to eliminate valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business.

 

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

 

About Sapiens

 

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a global leader in intelligent insurance software solutions. With Sapiens’ robust platform, customer-driven partnerships, and rich ecosystem, insurers are empowered to future-proof their organizations with operational excellence in a rapidly changing marketplace. We help insurers harness the power of AI and advanced automation to support core solutions for property and casualty, workers’ compensation, and life insurance, including reinsurance, financial & compliance, data & analytics, digital, and decision management. Sapiens boasts a longtime global presence, serving over 600 customers in more than 30 countries with its innovative SaaS offerings. Recognized by industry experts and selected for the Microsoft Top 100 Partner program, Sapiens is committed to partnering with our customers for their entire transformation journey and is continuously innovating to ensure their success.

 

Investor and Media Contact

 

Yaffa Cohen-Ifrah

Chief Marketing Officer and Head of
Investor Relations, Sapiens

Yaffa.cohen-ifrah@sapiens.com

+1 917-533-4782

Investor Contacts

 

Brett Maas
Managing Partner, Hayden IR
+1 646-536-7331
Brett.Maas@HaydenIR.com

 

Kimberly Rogers
Managing Director, Hayden IR
+1 541-904-5075
kim@HaydenIR.com

 

3


 

Forward Looking Statements

 

Certain matters discussed in this press release that are incorporated herein and therein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “will,” “plan” and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to:  the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; the global macroeconomic environment, including headwinds caused by inflation, relatively high interest rates, potentially unfavorable currency exchange rate movements, and uncertain economic conditions, and their impact on our revenues, profitability and cash flows; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers’ systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the coronavirus epidemic,  and fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company.

 

While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2024, to be filed in the near future, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

 

4


 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENT OF INCOME

U.S. dollars in thousands (except per share amounts)

 

    Three months ended     Nine months ended  
    September 30,     September 30,  
    2025     2024     2025     2024  
    (unaudited)     (unaudited)     (unaudited)     (unaudited)  
                         
Revenue     152,319       137,025       430,026       408,074  
Cost of revenue     85,010       76,729       240,166       230,114  
                                 
Gross profit     67,309       60,296       189,860       177,960  
                                 
Operating expenses:                                
Research and development, net     21,182       16,449       56,291       49,779  
Selling, marketing, general and administrative     28,367       22,101       77,816       64,030  
Total operating expenses     49,549       38,550       134,107       113,809  
                                 
Operating income     17,760       21,746       55,753       64,151  
                                 
Financial and other (income) expenses, net     (239 )     (913 )     (2,839 )     (3,114 )
Taxes on income     3,621       4,324       11,794       12,812  
                                 
Net income     14,378       18,335       46,798       54,453  
                                 
Attributable to non-controlling interest     78       -       330       141  
                                 
Net income attributable to Sapiens’ shareholders     14,300       18,335       46,468       54,312  
                                 
Basic earnings per share     0.26       0.33       0.83       0.97  
                                 
Diluted earnings per share     0.25       0.33       0.83       0.97  
                                 
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)     55,927       55,854       55,954       55,799  
                                 
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)     56,432       56,308       56,222       56,151  

 

5


 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

 

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

 

    Three months ended     Nine months ended  
    September 30,     September 30,  
    2025     2024     2025     2024  
    (unaudited)     (unaudited)     (unaudited)     (unaudited)  
                         
GAAP revenue     152,319       137,025       430,026       408,074  
Non-GAAP revenue     152,319       137,025       430,026       408,074  
                                 
GAAP gross profit     67,309       60,296       189,860       177,960  
Amortization of capitalized software     1,728       1,470       4,914       4,584  
Amortization of other intangible assets     1,651       1,043       3,747       3,630  
Non-GAAP gross profit     70,688       62,809       198,521       186,174  
                                 
GAAP operating income     17,760       21,746       55,753       64,151  
Gross profit adjustments     3,379       2,513       8,661       8,214  
Capitalization of software development     (1,715 )     (1,834 )     (5,445 )     (5,374 )
Amortization of other intangible assets     2,412       1,276       6,066       3,732  
Stock-based compensation     861       646       2,553       2,229  
Costs related to Sapiens acquisition by Advent     2,324       -       2,324       -  
Acquisition-related costs *)     453       754       3,196       1,248  
Non-GAAP operating income     25,474       25,101       73,108       74,200  
                                 
GAAP net income attributable to Sapiens’ shareholders     14,300       18,335       46,468       54,312  
Operating income adjustments     7,714       3,355       17,355       10,049  
Taxes on income     (1,494 )     (599 )     (3,319 )     (1,808 )
Non-GAAP net income attributable to Sapiens’ shareholders     20,520       21,091       60,504       62,553  

 

(*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as completed or prospective third-party services, such as tax, accounting and legal rendered.

 

6


 

Adjusted EBITDA Calculation
U.S. dollars in thousands

 

    Three months ended     Nine months ended  
    September 30,     September 30,  
    2025     2024     2025     2024  
                         
GAAP operating profit     17,760       21,746       55,753       64,151  
                                 
Non-GAAP adjustments:                                
Amortization of capitalized software     1,728       1,470       4,914       4,584  
Amortization of other intangible assets     4,063       2,319       9,813       7,362  
Capitalization of software development     (1,715 )     (1,834 )     (5,445 )     (5,374 )
Stock-based compensation     861       646       2,553       2,229  
Costs related to Sapiens acquisition by Advent     2,324       -       2,324       -  
Compensation related to acquisition and acquisition-related costs     453       754       3,196       1,248  
                                 
Non-GAAP operating profit     25,474       25,101       73,108       74,200  
                                 
Depreciation     1,059       1,288       3,088       3,480  
                                 
Adjusted EBITDA     26,533       26,389       76,196       77,680  

 

Summary of NON-GAAP Financial Information
U.S. dollars in thousands (except per share amounts)

 

    Q3 2025     Q2 2025     Q1 2025     Q4 2024     Q3 2024  
                               
Revenues     152,319       141,602       136,105       134,305       137,025  
Gross profit     70,688       64,838       62,995       62,692       62,809  
Operating income     25,474       23,077       24,557       24,468       25,101  
Adjusted EBITDA     26,533       24,141       25,529       25,359       26,389  
Net income to Sapiens’ shareholders     20,520       19,305       20,679       20,710       21,091  
                                         
Diluted earnings per share     0.36       0.34       0.37       0.37       0.37  

 

Annual Recurring Revenue (“ARR”)

U.S. dollars in thousands 

 

    Three months ended  
    September 30,  
    2025     2024  
Annual Recurring Revenue     219,715       173,414  

 

7


 

Non-GAAP Revenues by Geographic Breakdown
U.S. dollars in thousands

 

    Q3 2025     Q2 2025     Q1 2025     Q4 2024     Q3 2024  
                               
North America     64,291       59,782       56,871       56,753       55,755  
Europe     71,817       70,095       67,480       65,624       69,281  
Rest of the World     16,211       11,725       11,754       11,928       11,989  
                                         
Total     152,319       141,602       136,105       134,305       137,025  

 

Non-GAAP Revenue breakdown

U.S. dollars in thousands

 

    Three months ended     Nine months ended  
    September 30,     September 30,  
    2025     2024     2025     2024  
                         
Software products and re-occurring post-production services (*)     119,799       100,707       337,715       292,992  
Pre-production implementation services (**)     32,520       36,318       92,311       115,082  
                                 
Total Revenues     152,319       137,025       430,026       408,074  

 

    Three months ended     Nine months ended  
    September 30,     September 30,  
    2025     2024     2025     2024  
                         
Software products and re-occurring post-production services (*)     64,303       53,809       182,234       156,386  
Pre-production implementation services (**)     6,385       9,000       16,287       29,788  
                                 
Total Gross profit     70,688       62,809       198,521       186,174  

 

    Three months ended     Nine months ended  
    September 30,     September 30,  
    2025     2024     2025     2024  
                         
Software products and re-occurring post-production services (*)     53.7 %     53.4 %     54.0 %     53.4 %
Pre-production implementation services (**)     19.6 %     24.8 %     17.6 %     25.9 %
                                 
Gross Margin     46.4 %     45.8 %     46.2 %     45.6 %

 

(*) Software products and re-occurring post-production services include mainly subscription, term license, maintenance, application maintenance, cloud solutions and post-production services. This revenue stream is a mix of recurring and re-occurring in nature.

 

(**) Pre-production implementation services include mainly implementation services before go-live, which are one-time in nature.

 

8


 

Adjusted Free Cash-Flow

U.S. dollars in thousands

 

    Q3 2025     Q2 2025     Q1 2025     Q4 2024     Q3 2024  
                               
Cash-flow from operating activities     10,643       1,873       25,353       42,109       13,083  
Increase in capitalized software development costs     (1,715 )     (1,788 )     (1,942 )     (1,759 )     (1,834 )
Capital expenditures     (431 )     (1,003 )     (366 )     (419 )     (1,125 )
Free cash-flow     8,497       (918 )     23,045       39,931       10,124  
                                         
Cash payment related to Sapiens acquisition by Advent     165       -       -       -       -  
Cash payments attributed to acquisition-related costs(*) (**)     803       626       -       1,238       124  
                                         
Adjusted free cash-flow     9,465       (292 )     23,045       41,169       10,248  

 

(*) Included in cash-flow from operating activities

 

(**) Acquisition-related payments pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as completed or prospective third-party services, such as tax, accounting and legal rendered.

 

9


 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEET

U.S. dollars in thousands

 

    September 30,     December 31,  
    2025     2024  
    (unaudited)     (unaudited)  
ASSETS            
             
CURRENT ASSETS            
Cash and cash equivalents     82,200       163,690  
Short-term bank deposit     -       52,500  
Trade receivables, net and unbilled receivables     138,189       99,603  
Other receivables and prepaid expenses     31,363       19,350  
Total current assets     251,752       335,143  
                 
LONG-TERM ASSETS                
Property and equipment, net     10,268       10,656  
Severance pay fund     2,621       3,208  
Goodwill and intangible assets, net     430,900       302,472  
Operating lease right-of-use assets     21,201       20,746  
Other long-term assets     26,948       19,486  
Total long-term assets     491,938       356,568  
                 
TOTAL ASSETS     743,690       691,711  
                 
LIABILITIES AND EQUITY                
                 
CURRENT LIABILITIES                
Trade payables     13,218       8,414  
Current maturities of Series B Debentures     19,808       19,796  
Accrued expenses and other liabilities     91,650       77,390  
Current maturities of operating lease liabilities     6,351       6,440  
Deferred revenue     34,989       37,543  
Total current liabilities     166,016       149,583  
                 
LONG-TERM LIABILITIES                
Series B Debentures, net of current maturities     -       19,792  
Deferred tax liabilities     12,310       6,899  
Other long-term liabilities     11,511       10,331  
Long-term operating lease liabilities     17,376       17,719  
Accrued severance pay     9,285       7,758  
Total long-term liabilities     50,482       62,499  
                 
REDEEMABLE NON-CONTROLLING INTEREST     13,724       -  
                 
EQUITY     513,468       479,629  
                 
TOTAL LIABILITIES AND EQUITY     743,690       691,711  

 

10


 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONSOLIDATED STATEMENT OF CASH FLOW
U.S. dollars in thousands

 

    For the nine months ended September 30,  
    2025     2024  
    (unaudited)     (unaudited)  
Cash flows from operating activities:            
Net income     46,797       54,453  
Reconciliation of net income to net cash provided by operating activities:                
Depreciation     3,088       3,480  
Amortization of capitalized software and other intangible assets     14,727       11,946  
Accretion of discount on Series B Debentures     17       32  
Capital loss from sale of property and equipment     1       13  
Stock-based compensation related to options issued to employees     2,553       2,229  
                 
Net changes in operating assets and liabilities, net of amount acquired:                
Increase in trade receivables, net and unbilled receivables     (21,034 )     (20,640 )
Decrease in deferred tax liabilities, net     (3,325 )     (2,280 )
Increase in other operating assets     (138 )     (908 )
Increase in trade payables     3,129       1,989  
Decrease in other operating liabilities     (1,880 )     (5,154 )
Decrease in deferred revenues     (7,279 )     (5,684 )
Increase in accrued severance pay, net     1,213       640  
Net cash provided by operating activities     37,869       40,116  
                 
Cash flows from investing activities:                
Purchase of property and equipment     (1,864 )     (2,306 )
Proceeds from deposits     52,366       36,360  
Proceeds from sale of property and equipment     64       49  
Payments for business acquisitions, net of cash acquired     (106,683 )     (375 )
Capitalized software development costs     (5,445 )     (5,374 )
Net cash provided by (used in) investing activities     (61,562 )     28,354  
                 
Cash flows from financing activities:                
Proceeds from employee stock options exercised     -       98  
Distribution of dividend     (37,037 )     (29,789 )
Repayment of Series B Debenture     (19,796 )     (19,796 )
Acquisition of non-controlling interest     -       (4,131 )
Acquisition deferred payment     (455 )     -  
Net cash used in financing activities     (57,288 )     (53,618 )
                 
Effect of exchange rate changes on cash and cash equivalents     (509 )     4,584  
                 
Increase (decrease) in cash and cash equivalents     (81,490 )     19,436  
Cash and cash equivalents at the beginning of period     163,690       126,716  
                 
Cash and cash equivalents at the end of period     82,200       146,152  

  

11


 

Debentures Covenants

 

As of September 30, 2025, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

 

Covenant 1

 

Target shareholders’ equity (excluding non-controlling interest): above $120 million.

 

Actual shareholders’ equity (excluding non-controlling interest) equal to $513.5 million.

 

Covenant 2

 

Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company’s Series B Debentures) below 65%.

 

Actual ratio of net financial indebtedness to net capitalization equal to (13.79)%.

 

Covenant 3

 

Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.

 

Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (0.61).

 

12